SIBIA Neurosciences (SIBI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SIBIA Neurosciences (SIBI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (265)	1/11/1999 7:19:00 AM
From: Mike McFarland	Read Replies (2) of 579

...and around and around we go, no surprise tho --this came from KDUS, so it carries their slant Cadus Announces Decision by U.S. Patent Office to Re-Examine Patent at Issue in Sibia Lawsuit biz.yahoo.com The re-examination by the Patent Office is independent of the verdict by the jury. The Patent Office makes its own determination of patentability. A final decision by the Patent Office that the claims of the '629 patent are invalid would take precedence over the jury verdict Possible trade: If SIBI slips a bit today, a person could hold a few extra shares for the inevitable Sibia response later this week. biz.yahoo.com The jury found that the methods used by Cadus infringed all eleven claims of the patent asserted by SIBIA and that the patent was valid and enforceable. Unfortunately my wife is not a patent attny, but eleven for eleven is pretty good...remember Spinal Tap?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next